The New York State Psychiatric Institute has suspended all human research trials after a person taking part in a Parkinson's drug trial killed themselves. A total of 417 research studies, with a budget of $86 million, were halted as federal regulators probe the center's safety protocols after a man who was part of the group trialling levodopa - a dopamine replacement agent - died. Dr. Bret R. Rutherford, an associate professor of psychiatry at Columbia University was leading the study - which tested the drug for Parkinson’s disease.
Load More
Load More